Across TCGA pan-cancer cohorts, STON1-GTF2A1L RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of STON1-GTF2A1L’s most consistent transcriptional readouts.
The strongest signal is observed in kidney chromophobe (KICH), where STON1-GTF2A1L RNA is repressed in tumor relative to normal tissue. In most cancer types STON1-GTF2A1L is over-expressed in tumor, although a few such as KICH and BLCA show the opposite, repressed pattern.
KICH, BLCA, and THCA are the cancer types where STON1-GTF2A1L tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in STON1-GTF2A1L RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.